Clinical Trial Update: Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A phase 3 trial of apatinib for advanced non-squamous non-small cell lung cancer is ongoing, with the current status not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN